BackNotable Labs Overview

Notable Labs EBIT

Notable Labs's EBIT is $-13M, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$5.38M
↓ 1545.26% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$12.92M

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Notable Labs (NTBL) FAQ

As of the most recent data (June 2024), NTBL shows a EBIT of $-13M. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.

The Healthcare sector average EBIT is about $110B. Notable Labs is at $-13M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how NTBL stacks up against individual peers as well.

Tracking NTBL's ebit over time shows whether Notable Labs is scaling, shrinking, or reshaping that part of the business. The current reading is $-13M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Notable Labs's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-13M) with ownership activity and broader fundamentals.

The Healthcare average EBIT is about $110B, while NTBL is at $-13M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.